Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submission for suzetrigine, an investigational, oral,...
Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced that Molecular Pathology Laboratory Network, Inc., (MPLN) is now the first national molecular reference...
GSK plc and Flagship Pioneering (Flagship), the bioplatform innovation company, announced they have entered a collaboration with the goal of discovering and developing a...
Amneal Pharmaceuticals, Inc. announced that it has received New Drug Application (“NDA”) approval from the U.S. Food and Drug Administration (FDA) for its new...
Windtree Therapeutics, Inc, a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, announced an update of istaroxime...
